A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...
The origin of many diseases begins at the cellular level and involves multiple molecular interactions. However, previous methods have struggled to accurately observe changes in individual cells.
Specific neurons in the motor cortex of the brain are linked to Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), offering targets for tailored therapies.
Precision oncology is shifting toward comprehensive transcriptome profiling to reveal fusions, splice variants, and expression changes that DNA panels miss. Yet obtaining reliable data from degraded ...
Explore the breakthrough of lab-made lncRNA by University of Toronto Engineering for new drug discovery potential.
The three-year UNITED 2.0 initiative will use advanced DNA testing and AI to give doctors a more complete picture of a patient’s cancer and help match treatments more precisely.
Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
1don MSN
Certain neurons are especially susceptible to ALS and frontotemporal dementia, researchers discover
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia ...
Researchers identify five specific neuron subgroups in the motor cortex most vulnerable to TDP-43 protein clumps in ALS and Frontotemporal Dementia.
Morning Overview on MSN
Single-cell breakthrough decodes transcriptome, epigenome & 3D genome at once
A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results